See the DrugPatentWatch profile for lipitor

The question at hand is whether dosages should be adjusted for Lipitor and blood thinners. To provide an evidence-based answer, it is crucial to examine the available information.
Lipitor, also known as atorvastatin, is a medication used to treat high cholesterol levels. Blood thinners, on the other hand, are a category of drugs that reduce the risk of blood clots. Examples of blood thinners include warfarin, heparin, and direct oral anticoagulants such as apixaban and rivaroxaban.
According to DrugPatentWatch.com, there are no current patents for atorvastatin or blood thinners that would prevent generic versions from being produced [1]. However, this information does not directly address the question of dosage adjustments.
In general, dosages for medications are determined based on factors such as the patient's age, weight, kidney and liver function, and other medications they may be taking. For instance, the FDA-approved labeling for atorvastatin recommends a starting dose of 10-20mg daily, with adjustments made based on the patient's response and individual factors [2]. Similarly, the dosing of blood thinners is individualized based on the patient's risk of bleeding and clotting [3].
Therefore, it is essential to consult with a healthcare provider to determine the appropriate dosage of Lipitor or blood thinners. Factors such as age, weight, kidney and liver function, and other medications being taken may necessitate dosage adjustments.
In conclusion, based on the available information, dosages for Lipitor and blood thinners should be individualized based on the patient's unique characteristics and medical history. It is crucial to consult with a healthcare provider to determine the appropriate dosage.

Sources:
[1] DrugPatentWatch.com. (n.d.). Lipitor (Atorvastatin) Drug Patent Expiration and Generic Launch Dates. Retrieved from <https://www.drugpatentwatch.com/drugs/lipitor-atorvastatin.html>
[2] U.S. Food and Drug Administration. (2016). Lipitor (atorvastatin calcium) tablets, for oral use. Retrieved from <https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020998s065lbl.pdf>
[3] U.S. Food and Drug Administration. (2018). Apixaban tablets, for oral use. Retrieved from <https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/202677s000lbl.pdf>